Claude H. Nash

Claude H. Nash

President presso SelectX Pharmaceuticals, Inc.

Health Technology
Consumer Services
Consumer Durables

Profilo

Claude H.
Nash
is the founder of Shire ViroPharma, Inc. He currently holds the following positions: Independent Director at Adolor Corp.
since 2011, Director at Cerecin, Inc. since 2019, and President, Secretary & Treasurer at SelectX Pharmaceuticals, Inc. since 2014.
Previously, he served as Chairman & Chief Executive Officer at Bloodstone Ventures Plc, Senior Director-Biology at Sterling Winthrop, Inc., Head-Fermentation Technology Group at Eli Lilly & Co., Vice President-Infectious Disease & Tumor Biology at Schering-Plough Research Institute from 1983 to 1994, and Principal at Smith Kline & French Laboratories Ltd.
He obtained a doctorate degree from Colorado State University and an undergraduate degree from Lamar University.

Posizioni attive di Claude H. Nash

SocietàPosizioneInizio
Director/Board Member 01/01/2000
Director/Board Member 20/12/2019
President -
Tutte le posizioni attive di Claude H. Nash

Precedenti posizioni note di Claude H. Nash

SocietàPosizioneFine
Chief Executive Officer 01/08/2000
Corporate Officer/Principal 01/01/1994
Corporate Officer/Principal -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Claude H. Nash

Formazione di Claude H. Nash

Colorado State University Doctorate Degree
Lamar University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Claude H. Nash

Relazioni

57

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
ELI LILLY AND COMPANY

Health Technology

Aziende private8

Health Technology

Health Technology

Health Technology

Consumer Durables

Health Technology

Bloodstone Ventures Plc

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Claude H. Nash